#United States #Denver #Powered Research #AI in retina #Neovascular disease

Artificial Intelligence in Ophthalmology: Unveiling New Frontiers at ARVO 2026

The ARVO 2026 conference, held in Denver, Colorado, highlights cutting-edge advancements in vision science, with a particular focus on the intersection of artificial intelligence (AI) and ophthalmology. The Powered Research team is presenting two significant abstracts that delve into the use of AI to quantify ocular conditions, enhancing existing methodologies in assessing retinal diseases and corneal health.

AI to Quantify Vascular Leakage in Retinal Diseases

One of the highlighted studies, titled _Artificial Intelligence to Quantify Leakage of Neovascular Tufts from Fundus Imaging_, addresses the critical challenge of accurately measuring vascular leakage in conditions resembling wet age-related macular degeneration and diabetic retinopathy. These conditions often present complex issues of vascular health, making traditional evaluative techniques less effective.

The research team utilized a machine learning-based image analysis tool to rapidly assess total vascular area from fluorescein angiography (FA) data collected in preclinical settings. The study involved inducing neovascular tufts in Dutch Belted rabbits using a specialized model and comparing results from traditional evaluation methods against those from their novel AI approach.

The findings revealed a significant decrease in the average total vascular area, showcasing the effectiveness of the AI-assisted analysis over a four-week therapeutic period. Notably, this method allows for high-throughput, noninvasive testing of treatments aimed at managing neovascular diseases, which could ultimately accelerate the development of new therapies.

Exploring Corneal Neuropathy Across Rabbit Strains

The second abstract presented by the Powered Research team, _Correlation Between Nerve Density and Corneal in Two Rabbit Strains_, emphasizes the necessity of understanding corneal health across different rabbit strains to make insights applicable to human conditions. This study assessed the differences in corneal sensitivity and nerve density between New Zealand White (NZW) and Dutch Belted (DB) rabbits.

With extensive analysis, the results indicated that NZW rabbits demonstrated significantly higher central corneal sensitivity compared to their pigmented counterparts. This differential could play a crucial role in studying conditions affecting ocular surface health and the therapeutic interventions derived thereof. Interestingly, superficial nerve densities appeared higher in DB rabbits, raising questions about the relationship between nerve structure and functional outcomes.

Such findings underscore the importance of selecting appropriate animal models for ophthalmic research, promising more translatable results that align with human conditions. The implications of these insights paint a hopeful picture for future therapeutic advancements.

Powered Research: A Leader in Preclinical Studies

Powered Research is at the forefront of preclinical research in ophthalmology, with a focus on developing non-GLP preclinical data packages that aid clients in advancing their therapeutic strategies. Their expertise in utilizing AI for rapid results positions them as leaders in the field, notably enhancing research quality and efficiency.

These presentations at ARVO 2026 signal a paradigm shift in how AI can influence the study of eye health, offering innovative solutions that transcend traditional research methodologies. As ongoing research continues to unfold, the integration of AI within ophthalmology promises to pave the way toward better treatment options for patients afflicted by retinal and corneal diseases. Discover more about Powered Research and their groundbreaking work at Powered Research.